2022 ISPE Annual Meeting & Expo

Oct 29, 2022 ‐ Nov 1, 2022



Sessions

Workshop: Career Connections - Developing Your Personal Brand

Oct 30, 2022 1:00pm ‐ Oct 30, 2022 4:00pm

Workshop: Career Connections - Developing Your Personal Brand |Presented by Women in Pharma®
Bring your electronic device (laptop preferred)
Phil Gerbyshak and Kara Kirby will be on site to lead a highly interactive session and hands-on workshop to level up your personal brand and LinkedIn profile.
Do you have a personal brand? Is it on purpose? Whether you like it or not, hiring managers and HR professionals judge you based on what they find - and don’t - from you online. Want to stand out from your peers and your competition so you can get hired for the job of your dreams? 
In the first half of this workshop,  you’ll discover how to pursue your leadership potential by overcoming the imposter syndrome, learning the skills to bring the best out of any team, and honing your communication skills. 
In the second half of this workshop, you will translate what you have learned about yourself and your teams to further develop your personal brand.  This immersive, hands-on workshop is designed to elevate your personal LinkedIn Profile to take it to the next level.  Whether you are looking to build meaningful connections, expand your network, or stand out from the best, this workshop will show you tactics to level up your LinkedIn profile.
Phil Gerbyshak is a LinkedIn Sales Trainer, Sr. Sales Enablement Program Manager at BambooHR, and talk show host of ‘The Sales and Leadership Show’ on sales, leadership, and digital strategies.  He has been doing custom LinkedIn training since 2010.
Kara Kirby is a leadership consultant and CEO of Insights Leadership group and podcast host of Pop! On Leadership. She works with companies worldwide to guide their pursuit of being the best places to work.

Speaker(s):

Facility of the Year (FOYA) Dinner and Awards

Oct 30, 2022 7:00pm ‐ Oct 30, 2022 8:00pm

Join ISPE to celebrate the 2022 Facility of the Year Awards Celebratory Reception and Banquet where we will formally recognize and celebrate the 2022 Category winners' achievements at ISPE’s premier award presentation ceremony and dinner.


Opening Keynote Session iconOpening Keynote Session

Preview Available

Opening Keynote Session

Oct 31, 2022 7:30am ‐ Oct 31, 2022 9:15am

Session Leader(s): Speaker(s):

Pharma 4.0™ - Industry Status & Methodologies

Oct 31, 2022 10:00am ‐ Oct 31, 2022 11:30am

Digitalization opens new horizons to achieve new levels of connectivity, transparency, agility and productivity through the application of faster and more accurate information to enable (automated) decision-making. The fundamentals of the digitalization process lies in in the structure underneath the data being created, used, reported, stored, and destroyed. 

Currently, in the Pharma 3.0 environment the approach for automation is in a process-centric environment. However, moving to Pharma 4.0™, a different approach in which the data life cycle is centralized, will lead to a data-centric approach. Each data life cycle needs to be completed and aligned to be considered a data set. In current production processes different data sets are created for each process. Visualizing the data sets amongst different process steps will automatically trigger missing data, misaligned data or duplicate data. Moving to Pharma 4.0™, each data set will need to be assessable at any time in any business layer. 

Therefore, a system needs to be in place to show the data architecture and how it interacts with various processes. This session will discuss the status and examples of practical transformational methodologies to a digitalized Pharma 4.0™ Operating Model-based organization.

Session Leader(s): Speaker(s):
  • Mrs. Teresa Minero, Founder & CEO, LifeBee - Digitalizing Life Sciences
  • Mr. Wolfgang Winter, Director, Informatics Platform R&D, Agilent Technologies R&D Mktg GmbH & Co KG
  • Robin Schiemer, PhD Candidate, Karlsruhe Institute of Technology
  • Josef Trapl, Head of MSci Innovation, GMS / Manufacturing Science, Takeda Pharmaceutical International AG
  • Ms. Laura Kuger, PhD Candidate and Member, ISPE D/A/CH Emerging Leaders & Students and WIP, Karlsruhe Institute of Technology

Transportable, Small Footprint Biopharmaceutical Manufacturing Facilities: A Regulatory Perspective

Oct 31, 2022 10:00am ‐ Oct 31, 2022 11:30am

Today’s manufacturing platforms and associated analytics are smaller, lighter, and significantly more modular versus their predecessors. These technological advances are enabling much smaller factory footprints, allowing a transportable manufacturing platform and facilities paradigm to gain considerable traction as a viable alternative to more traditional equipment train and facilities constructs. Flexible, transportable units have the potential to address variable demand through scale-out, take advantage of off-site fabrication principles, and may be installed more quickly than for traditional construction practices. 

Consequently, when business needs change, as they so often do, manufacturing units can be relocated. The potential financial, technical, quality, and regulatory challenges vs. opportunities associated with the movability of the manufacturing environment will be addressed and case studies will be presented to illustrate the challenges vs. benefits of mobility and operating a mobile facility. 

Presentations will provide perspectives on advanced biopharmaceutical manufacturing trends drawn from the work of ISPE's Product Quality Lifecycle Implementation (PQLI)® team and subteam, ISPE PQLI Transportable/Point of Care Manufacturing Technology team.

Session Leader(s): Speaker(s):
  • Mr. Dennis Powers, Vice President of Business Development & Design Consulting, G-CON Manufacturing
  • Richard Panton, Principal Engineer, Roche Genentech
  • Thomas O'Connor, Division Director, Division of Product Quality Research, US Food and Drug Administration

Building a Quality Organization

Oct 31, 2022 10:00am ‐ Oct 31, 2022 11:30am

While pharmaceutical GMPs and their associated guidelines recommend a quality unit that is independent of the manufacturing unit, they give little or no information on its organizational construct. This session will explore how to build a pharmaceutical quality system to meet ICH Q10 expectations to “assure the desired product quality is routinely met, suitable process performance is achieved, the set of controls are appropriate, improvement opportunities are identified and evaluated, and the body of knowledge is continually expanded.”

Additionally, the speakers will address how to build an organization with a sustainable quality culture and meet all necessary compliance requirements internationally. Senior leaders from a start-up company (Phlow), a spin-off company (Organon), and a rapidly growing company (Moderna) will discuss how to balance addressing compliance needs and planning for expanding roles, commensurate with evolving company capabilities and capacity.

Session Leader(s):
  • Christine Moore, PhD, Executive Director, Quality Systems & Compliance, Organon LLC
Speaker(s):

GPG Good Engineering Practices at Operation Warp Speed

Oct 31, 2022 10:00am ‐ Oct 31, 2022 11:30am

The COVID pandemic, and more specifically, Operation Warp Speed driven projects, rocked the global supply chain and taught the industry that the paradigm of typical project durations could be shattered. The success of a number of these projects has driven the industry to expect an unprecedented level of speed on future projects. Good Engineering Practices are critical to the delivery of compliant biopharmaceutical projects; however, their application is absolutely crucial as design, procurement and verification activities are conducted throughout fast-tracked projects. 

This session will describe the concepts of the guide, the principles and drivers behind its revision, and the practical application of the guide for customers’ use. In addition, speakers will provide a case study of a BARDA funded Operation Warp Speed BSL-2 Aseptic / Isolated Formulation and Filling Facility with a project duration of 11 months from concept to aseptic process simulation readiness, which completely challenged the paradigm and basic understanding of how fast a project would be delivered from concept through CQV.

Session Leader(s):
  • Michael Westerman, Vice President, CQV Operations, IPS - Integrated Project Services, LLC
Speaker(s):
  • Mr. Chip Bennett, PMP, Associate Director, Global C&Q, CAI
  • Mr. Paul F. Valerio, Director of Process Technology / Senior Associate, IPS - Integrated Project Services, LLC
  • Jeffrey Adcock, Global Director, Management & Cost Control, Emergent Solutions

Patient Centric Development Strategies

Oct 31, 2022 10:00am ‐ Oct 31, 2022 11:30am

In this session, experts will discuss patient centric approaches to drug development, focusing in on applications to product quality. The session will start with a broad discussion of patient centric development strategies and subsequently narrow in on how these ideas can be applied to ensure drug quality. The development of patient centric or clinically relevant specifications builds on existing industry guidance and utilizes the science and knowledge generated through the development and the lifecycle of a pharmaceutical product. By taking this understanding and applying it to establish specifications that focus on the patient, rather than simply the batch data available at time of clinical/marketing application, significant benefits can be gained for both regulatory agencies and industry.

The session will cover the application of patient centric specifications and discuss how revisions to ICH Q6A/B could embrace these ideas. Wider adoption of these principles could form the cornerstone to achieving global regulatory harmonization, reducing the complexity of managing a product through its lifecycle, reducing environmental impact from our pharmaceutical processes, improving supply chain robustness, and potentially minimizing drug shortage and disruption of supply of medicines to patients.

Speaker(s):

Concurrent Session: Pharma 4.0™ - Industry Status & Methodologies

Oct 31, 2022 11:00am ‐ Oct 31, 2022 12:30pm

Concurrent Session: Pharma 4.0™ - Industry Status & Methodologies | Digitalization opens new horizons to achieve new levels of connectivity, transparency, agility and productivity through the application of faster and more accurate information to enable (automated) decision-making. The fundamentals of the digitalization process lies in in the structure underneath the data being created, used, reported, stored, and destroyed.  Currently, in the Pharma 3.0 environment the approach for automation is in a process-centric environment. However, moving to Pharma 4.0™, a different approach in which the data life cycle is centralized, will lead to a data-centric approach. Each data life cycle needs to be completed and aligned to be considered a data set. In current production processes different data sets are created for each process. Visualizing the data sets amongst different process steps will automatically trigger missing data, misaligned data or duplicate data. Moving to Pharma 4.0™, each data set will need to be assessable at any time in any business layer. Therefore, a system needs to be in place to show the data architecture and how it interacts with various processes. This session will discuss the status and examples of practical transformational methodologies to a digitalized Pharma 4.0™ Operating Model-based organization.

Speaker(s):
  • Mr. Wolfgang Winter, Director, Informatics Platform R&D, Agilent Technologies R&D Mktg GmbH & Co KG
  • Ms. Laura Kuger, PhD Candidate and Member, ISPE D/A/CH Emerging Leaders & Students and WIP, Karlsruhe Institute of Technology
  • Mr. Christian Woelbeling, Executive Industry Advisor, Körber
  • Josef Trapl, Head of MSci Innovation, GMS / Manufacturing Science, Takeda Pharmaceutical International AG
  • Mrs. Teresa Minero, Founder & CEO, LifeBee - Digitalizing Life Sciences

Concurrent Session: Transportable, Small Footprint Biopharmaceutical Manufacturing Facilities: A Regulatory Perspective 

Oct 31, 2022 11:00am ‐ Oct 31, 2022 12:30pm

Concurrent Session: Transportable, Small Footprint Biopharmaceutical Manufacturing Facilities: A Regulatory Perspective | Today’s manufacturing platforms and associated analytics are smaller, lighter, and significantly more modular versus their predecessors. These technological advances are enabling much smaller factory footprints, allowing a transportable manufacturing platform and facilities paradigm to gain considerable traction as a viable alternative to more traditional equipment train and facilities constructs. Flexible, transportable units have the potential to address variable demand through scale-out, take advantage of off-site fabrication principles, and may be installed more quickly than for traditional construction practices. Consequently, when business needs change, as they so often do, manufacturing units can be relocated.   The potential financial, technical, quality, and regulatory challenges vs. opportunities associated with the movability of the manufacturing environment will be addressed and case studies will be presented to illustrate the challenges vs. benefits of mobility and operating a mobile facility. Presentations will provide perspectives on advanced biopharmaceutical manufacturing trends drawn from the work of ISPE's Product Quality Lifecycle Implementation (PQLI)® team and subteam, ISPE PQLI Transportable/Point of Care Manufacturing Technology team.

Speaker(s):